top of page
Regulatory aspects of vaccine development
This two-day interactive training workshop on vaccine development will introduce participants to planning a regulatory strategy for vaccines with emphasis on the early phases of development. Day 1 will focus on prophylactic vaccines while day 2 will focus on cancer vaccines. The workshop will be designed based on the current bottlenecks and upcoming innovative approaches while planning a regulatory strategy.
31 December 2022
28-29 March, 2023
The European Infrastructure for Translational Medicine (EATRIS)
Amsterdam, The Netherlands
Participant Nr.: 20
Lauranne Duquenne firstname.lastname@example.org
The course is designed for professionals working on vaccine development who are in need of an introduction to the regulatory issues associated with the field. Day 1 will focus on prophylactic vaccines, including lectures and case studies on how to navigate the regulatory maze and how to plan a regulatory strategy, preclinical and Phase I-II of vaccine development, how to prepare a dossier for Medicine Agencies, CMC development. Day 2 will focus on cancer vaccines, with an introduction to the scientific part to understand the regulatory part better.”
Day 1 – Classic/prophylactic vaccines for infectious diseases
How to navigate the regulatory maze and how to plan a regulatory strategy
CMC vaccine development
Preclinical vaccine development: Animal testing
Early phase clinical trials and clinical trials application
How to bring products to patients: Prepare a dossier
Day 2 – Cancer and therapeutic vaccines
Scientific basis for cancer vaccines
Cancer vaccines vs classical vaccines vs ATMPs
Vaccine development when dealing with a pandemic
Giovanni Migliaccio, Scientific Director of the Centro Valutazioni Biologiche e Farmacologiche (IT) and Senior Advisor for EATRIS
Leo van der Pol, Principal Scientist at Intravacc (NL)
Christopher Mann, Scientific & Regulatory Affairs Director at Asphalion (ES)
Lucia Gabriele, Head of Tumor Immunology Section, Department of Oncology and Molecular Medicine (ISS, Rome), and Co‐Chair of Vaccine, Inflammation and Immunomonitoring Platform of EATRIS
Learn how to plan a regulatory strategy from the early phases of development and prepare a well-organised dossier in a changing environment.
Who should apply
Vaccine developers and European researchers from industry and academia.
Accommodation: Travel Costs are not included.
Kindly note that not all courses are open for application submission, check open calls to know which for which courses you can apply for at the moment.
Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter
bottom of page